Concepts (328)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Density | 28 | 2022 | 99 | 7.790 |
Why?
|
| Resistance Training | 38 | 2022 | 209 | 5.700 |
Why?
|
| Body Composition | 31 | 2022 | 262 | 4.260 |
Why?
|
| Muscle, Skeletal | 44 | 2025 | 622 | 3.730 |
Why?
|
| Muscle Strength | 32 | 2021 | 228 | 3.330 |
Why?
|
| Vibration | 14 | 2022 | 78 | 2.990 |
Why?
|
| Exercise | 31 | 2025 | 469 | 2.920 |
Why?
|
| Absorptiometry, Photon | 25 | 2022 | 100 | 2.660 |
Why?
|
| Osteoporosis | 7 | 2018 | 63 | 2.440 |
Why?
|
| Bone and Bones | 9 | 2021 | 74 | 2.180 |
Why?
|
| Postmenopause | 8 | 2022 | 83 | 1.990 |
Why?
|
| Tibia | 9 | 2021 | 38 | 1.720 |
Why?
|
| MicroRNAs | 3 | 2022 | 281 | 1.670 |
Why?
|
| Premenopause | 5 | 2021 | 20 | 1.620 |
Why?
|
| Female | 73 | 2025 | 14627 | 1.590 |
Why?
|
| Middle Aged | 60 | 2021 | 6894 | 1.540 |
Why?
|
| Male | 83 | 2025 | 13013 | 1.510 |
Why?
|
| Humans | 113 | 2025 | 27103 | 1.490 |
Why?
|
| Young Adult | 38 | 2025 | 2625 | 1.480 |
Why?
|
| Muscles | 4 | 2018 | 70 | 1.480 |
Why?
|
| Circulating MicroRNA | 2 | 2022 | 10 | 1.450 |
Why?
|
| Athletes | 2 | 2021 | 70 | 1.410 |
Why?
|
| Adipose Tissue | 9 | 2022 | 180 | 1.410 |
Why?
|
| Adult | 71 | 2025 | 7488 | 1.340 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2018 | 466 | 1.260 |
Why?
|
| Adiposity | 5 | 2021 | 88 | 1.230 |
Why?
|
| Regional Blood Flow | 23 | 2025 | 163 | 1.170 |
Why?
|
| Leg | 11 | 2020 | 131 | 1.170 |
Why?
|
| Sarcopenia | 3 | 2018 | 42 | 1.160 |
Why?
|
| Sports | 2 | 2022 | 23 | 1.140 |
Why?
|
| Exercise Test | 11 | 2020 | 248 | 0.970 |
Why?
|
| Thigh | 7 | 2017 | 39 | 0.970 |
Why?
|
| Aging | 15 | 2021 | 951 | 0.970 |
Why?
|
| Amputation | 3 | 2017 | 42 | 0.970 |
Why?
|
| Aged | 37 | 2021 | 5216 | 0.930 |
Why?
|
| Bed Rest | 2 | 2021 | 6 | 0.900 |
Why?
|
| Lower Extremity | 7 | 2017 | 84 | 0.880 |
Why?
|
| Biomarkers | 10 | 2022 | 738 | 0.870 |
Why?
|
| Athletic Performance | 5 | 2018 | 46 | 0.860 |
Why?
|
| Femur | 4 | 2011 | 21 | 0.850 |
Why?
|
| Sex Characteristics | 4 | 2020 | 163 | 0.850 |
Why?
|
| Head-Down Tilt | 2 | 2021 | 3 | 0.840 |
Why?
|
| Water Sports | 1 | 2022 | 1 | 0.800 |
Why?
|
| Muscle Contraction | 10 | 2018 | 167 | 0.790 |
Why?
|
| Lumbar Vertebrae | 8 | 2022 | 123 | 0.770 |
Why?
|
| Physical Exertion | 6 | 2020 | 102 | 0.730 |
Why?
|
| Mountaineering | 2 | 2010 | 6 | 0.720 |
Why?
|
| Adolescent | 31 | 2020 | 2987 | 0.720 |
Why?
|
| Cross-Sectional Studies | 12 | 2022 | 927 | 0.680 |
Why?
|
| Soccer | 1 | 2020 | 49 | 0.660 |
Why?
|
| Weightlessness Simulation | 1 | 2019 | 1 | 0.650 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2017 | 8 | 0.650 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2019 | 22 | 0.650 |
Why?
|
| Physical Fitness | 4 | 2012 | 61 | 0.640 |
Why?
|
| Space Flight | 2 | 2019 | 17 | 0.630 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 626 | 0.620 |
Why?
|
| Parathyroid Hormone | 1 | 2018 | 23 | 0.610 |
Why?
|
| Bicycling | 3 | 2019 | 40 | 0.600 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2018 | 32 | 0.600 |
Why?
|
| Bone Resorption | 2 | 2015 | 23 | 0.590 |
Why?
|
| Geriatric Assessment | 6 | 2014 | 87 | 0.580 |
Why?
|
| Hormones | 2 | 2022 | 41 | 0.550 |
Why?
|
| Cross-Over Studies | 8 | 2025 | 132 | 0.540 |
Why?
|
| Forearm | 4 | 2025 | 39 | 0.540 |
Why?
|
| Weight-Bearing | 6 | 2017 | 39 | 0.530 |
Why?
|
| Testosterone | 4 | 2013 | 70 | 0.520 |
Why?
|
| Exercise Tolerance | 4 | 2019 | 82 | 0.500 |
Why?
|
| Obesity | 1 | 2021 | 654 | 0.500 |
Why?
|
| Lactic Acid | 4 | 2018 | 89 | 0.490 |
Why?
|
| Musculoskeletal Diseases | 1 | 2014 | 5 | 0.480 |
Why?
|
| Weightlessness | 1 | 2014 | 5 | 0.480 |
Why?
|
| Creatine | 4 | 2010 | 32 | 0.480 |
Why?
|
| Astronauts | 1 | 2014 | 7 | 0.480 |
Why?
|
| Osteogenesis | 1 | 2015 | 40 | 0.470 |
Why?
|
| Health Status | 2 | 2017 | 145 | 0.470 |
Why?
|
| Analysis of Variance | 18 | 2015 | 388 | 0.470 |
Why?
|
| Dietary Supplements | 8 | 2020 | 221 | 0.460 |
Why?
|
| Women's Health | 1 | 2014 | 58 | 0.460 |
Why?
|
| Adaptation, Physiological | 9 | 2017 | 163 | 0.420 |
Why?
|
| Multiple Sclerosis | 3 | 2020 | 81 | 0.400 |
Why?
|
| Estrogen Replacement Therapy | 4 | 2010 | 42 | 0.400 |
Why?
|
| Vascular Stiffness | 4 | 2017 | 41 | 0.400 |
Why?
|
| Age Factors | 11 | 2017 | 721 | 0.390 |
Why?
|
| Osteoporosis, Postmenopausal | 3 | 2016 | 9 | 0.380 |
Why?
|
| Body Fat Distribution | 1 | 2011 | 15 | 0.380 |
Why?
|
| Brachial Artery | 3 | 2017 | 36 | 0.380 |
Why?
|
| Radius | 1 | 2011 | 3 | 0.370 |
Why?
|
| Weight Lifting | 3 | 2009 | 49 | 0.370 |
Why?
|
| Tourniquets | 4 | 2017 | 15 | 0.370 |
Why?
|
| Competitive Behavior | 1 | 2011 | 17 | 0.370 |
Why?
|
| Leptin | 1 | 2011 | 67 | 0.360 |
Why?
|
| Dietary Proteins | 2 | 2010 | 34 | 0.350 |
Why?
|
| Ischemia | 3 | 2017 | 83 | 0.350 |
Why?
|
| Muscular Atrophy | 1 | 2010 | 31 | 0.350 |
Why?
|
| Vascular Resistance | 2 | 2011 | 50 | 0.340 |
Why?
|
| Running | 4 | 2006 | 39 | 0.320 |
Why?
|
| Amputees | 1 | 2008 | 7 | 0.310 |
Why?
|
| Body Mass Index | 3 | 2021 | 389 | 0.310 |
Why?
|
| Sex Factors | 7 | 2017 | 452 | 0.300 |
Why?
|
| Hand Strength | 3 | 2025 | 36 | 0.300 |
Why?
|
| Hematocrit | 3 | 2018 | 26 | 0.290 |
Why?
|
| Time Factors | 13 | 2017 | 1570 | 0.290 |
Why?
|
| Physical Education and Training | 5 | 2011 | 45 | 0.280 |
Why?
|
| Blood Pressure | 5 | 2015 | 351 | 0.270 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 985 | 0.270 |
Why?
|
| Respiratory Tract Infections | 2 | 1996 | 35 | 0.260 |
Why?
|
| Patient Satisfaction | 2 | 1996 | 90 | 0.260 |
Why?
|
| Oxygen Consumption | 5 | 2019 | 179 | 0.250 |
Why?
|
| Collagen Type I | 3 | 2015 | 27 | 0.250 |
Why?
|
| Cytochrome P-450 CYP2C9 Inhibitors | 1 | 2025 | 3 | 0.250 |
Why?
|
| Cytochrome P-450 CYP2C9 | 1 | 2025 | 4 | 0.250 |
Why?
|
| Alkaline Phosphatase | 3 | 2015 | 31 | 0.250 |
Why?
|
| Fluconazole | 1 | 2025 | 8 | 0.250 |
Why?
|
| Vasoconstriction | 1 | 2025 | 45 | 0.240 |
Why?
|
| Sympathetic Nervous System | 1 | 2025 | 67 | 0.240 |
Why?
|
| Femur Neck | 2 | 2021 | 5 | 0.230 |
Why?
|
| Hypothyroidism | 2 | 1994 | 11 | 0.230 |
Why?
|
| Gymnastics | 1 | 2004 | 4 | 0.230 |
Why?
|
| Menstruation | 1 | 2004 | 9 | 0.230 |
Why?
|
| Physical Endurance | 5 | 2012 | 91 | 0.230 |
Why?
|
| Surveys and Questionnaires | 4 | 2019 | 928 | 0.230 |
Why?
|
| Double-Blind Method | 7 | 2025 | 405 | 0.230 |
Why?
|
| Peptides | 3 | 2015 | 280 | 0.210 |
Why?
|
| Hip Joint | 3 | 2012 | 18 | 0.210 |
Why?
|
| Quadriceps Muscle | 4 | 2020 | 61 | 0.200 |
Why?
|
| Interleukin-6 | 2 | 2022 | 189 | 0.200 |
Why?
|
| Health Promotion | 1 | 2004 | 169 | 0.200 |
Why?
|
| Anti-Bacterial Agents | 2 | 1996 | 497 | 0.190 |
Why?
|
| Isometric Contraction | 7 | 2020 | 118 | 0.190 |
Why?
|
| Muscle Fatigue | 4 | 2014 | 76 | 0.190 |
Why?
|
| Cardiac Output | 2 | 2019 | 36 | 0.190 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 1936 | 0.180 |
Why?
|
| Germany | 1 | 2021 | 24 | 0.180 |
Why?
|
| Prospective Studies | 2 | 2022 | 1219 | 0.180 |
Why?
|
| Postural Balance | 2 | 2011 | 38 | 0.180 |
Why?
|
| Myalgia | 1 | 2020 | 20 | 0.180 |
Why?
|
| Stroke | 2 | 2015 | 241 | 0.180 |
Why?
|
| Pelvic Bones | 1 | 2020 | 14 | 0.170 |
Why?
|
| Oklahoma | 7 | 2013 | 978 | 0.170 |
Why?
|
| Collagen | 1 | 2020 | 147 | 0.170 |
Why?
|
| Ultrasonography | 6 | 2016 | 229 | 0.170 |
Why?
|
| Upper Extremity | 3 | 2017 | 28 | 0.170 |
Why?
|
| Exercise Therapy | 2 | 2016 | 80 | 0.160 |
Why?
|
| Peptide Fragments | 1 | 2020 | 200 | 0.160 |
Why?
|
| Case-Control Studies | 4 | 2019 | 705 | 0.160 |
Why?
|
| Bone Remodeling | 1 | 2018 | 11 | 0.160 |
Why?
|
| Vitamin D | 1 | 2019 | 48 | 0.160 |
Why?
|
| Organ Specificity | 1 | 2018 | 81 | 0.160 |
Why?
|
| Predictive Value of Tests | 4 | 2018 | 472 | 0.150 |
Why?
|
| Genetic Markers | 1 | 2018 | 93 | 0.150 |
Why?
|
| Nutritional Status | 1 | 2019 | 75 | 0.150 |
Why?
|
| Up-Regulation | 1 | 2019 | 241 | 0.150 |
Why?
|
| Family Practice | 2 | 1996 | 45 | 0.150 |
Why?
|
| Plasma Volume | 1 | 2017 | 6 | 0.150 |
Why?
|
| Organ Size | 3 | 2015 | 85 | 0.140 |
Why?
|
| Artificial Limbs | 1 | 2017 | 5 | 0.140 |
Why?
|
| Biomechanical Phenomena | 3 | 2015 | 162 | 0.140 |
Why?
|
| Porosity | 1 | 2017 | 38 | 0.140 |
Why?
|
| Postoperative Period | 1 | 2017 | 67 | 0.140 |
Why?
|
| Practice Patterns, Physicians' | 2 | 1996 | 160 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 161 | 0.140 |
Why?
|
| Models, Cardiovascular | 1 | 2017 | 46 | 0.140 |
Why?
|
| Body Weight | 2 | 2018 | 248 | 0.130 |
Why?
|
| Torque | 2 | 2015 | 91 | 0.130 |
Why?
|
| Energy Metabolism | 3 | 1998 | 186 | 0.130 |
Why?
|
| Menstrual Cycle | 1 | 1995 | 23 | 0.130 |
Why?
|
| Respiration | 1 | 1995 | 45 | 0.130 |
Why?
|
| Acid Phosphatase | 1 | 2015 | 6 | 0.120 |
Why?
|
| Range of Motion, Articular | 2 | 2017 | 58 | 0.120 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 1 | 2015 | 7 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 65 | 0.120 |
Why?
|
| Physician-Patient Relations | 1 | 1996 | 112 | 0.120 |
Why?
|
| Cognitive Dysfunction | 1 | 2019 | 259 | 0.120 |
Why?
|
| Isoenzymes | 1 | 2015 | 86 | 0.120 |
Why?
|
| Aerospace Medicine | 1 | 2014 | 6 | 0.120 |
Why?
|
| Gait | 1 | 2015 | 58 | 0.120 |
Why?
|
| Body Weights and Measures | 1 | 2014 | 18 | 0.110 |
Why?
|
| Perception | 1 | 2015 | 83 | 0.110 |
Why?
|
| Linear Models | 1 | 2014 | 201 | 0.110 |
Why?
|
| Reference Values | 3 | 2012 | 199 | 0.110 |
Why?
|
| Skinfold Thickness | 4 | 2005 | 19 | 0.110 |
Why?
|
| Contraceptives, Oral | 1 | 1993 | 23 | 0.110 |
Why?
|
| Child, Preschool | 3 | 2008 | 1099 | 0.110 |
Why?
|
| Mass Screening | 1 | 1995 | 148 | 0.110 |
Why?
|
| Movement | 2 | 2010 | 95 | 0.110 |
Why?
|
| Foot Orthoses | 1 | 2012 | 3 | 0.100 |
Why?
|
| Hemodynamics | 3 | 2020 | 220 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 246 | 0.100 |
Why?
|
| Child | 4 | 2008 | 2159 | 0.100 |
Why?
|
| Physical Stimulation | 1 | 2012 | 70 | 0.100 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 1992 | 9 | 0.100 |
Why?
|
| Prolactin | 1 | 1992 | 16 | 0.100 |
Why?
|
| Healthy Volunteers | 2 | 2025 | 48 | 0.100 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2012 | 2 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 1995 | 270 | 0.100 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2013 | 291 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 153 | 0.100 |
Why?
|
| Osteocalcin | 2 | 2002 | 9 | 0.100 |
Why?
|
| Ethynodiol Diacetate | 1 | 2011 | 3 | 0.090 |
Why?
|
| Prevalence | 2 | 2008 | 478 | 0.090 |
Why?
|
| Military Personnel | 1 | 2012 | 45 | 0.090 |
Why?
|
| Growth Hormone | 1 | 1992 | 102 | 0.090 |
Why?
|
| Hypotension | 1 | 2011 | 18 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2020 | 396 | 0.090 |
Why?
|
| Human Growth Hormone | 1 | 2010 | 14 | 0.090 |
Why?
|
| Blood Glucose | 4 | 2019 | 306 | 0.090 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 104 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2012 | 862 | 0.090 |
Why?
|
| Hydrocortisone | 1 | 2010 | 88 | 0.090 |
Why?
|
| Milk Proteins | 1 | 2010 | 18 | 0.090 |
Why?
|
| Whey Proteins | 1 | 2010 | 12 | 0.090 |
Why?
|
| Logistic Models | 3 | 1996 | 398 | 0.080 |
Why?
|
| Task Performance and Analysis | 1 | 2010 | 41 | 0.080 |
Why?
|
| Physical Examination | 1 | 2010 | 51 | 0.080 |
Why?
|
| Drug Synergism | 1 | 2010 | 100 | 0.080 |
Why?
|
| Estrogens | 1 | 2010 | 56 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2009 | 209 | 0.080 |
Why?
|
| Electromyography | 3 | 2017 | 173 | 0.080 |
Why?
|
| United States | 3 | 2012 | 2060 | 0.080 |
Why?
|
| Whey | 1 | 2008 | 3 | 0.080 |
Why?
|
| Child Development | 1 | 1988 | 72 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 810 | 0.070 |
Why?
|
| Arteries | 3 | 2011 | 65 | 0.070 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2006 | 9 | 0.070 |
Why?
|
| Anti-Ulcer Agents | 1 | 2006 | 14 | 0.070 |
Why?
|
| Heartburn | 1 | 2006 | 26 | 0.070 |
Why?
|
| Prognosis | 1 | 2009 | 763 | 0.070 |
Why?
|
| Life Style | 2 | 2004 | 83 | 0.070 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2006 | 11 | 0.060 |
Why?
|
| Estradiol | 1 | 1987 | 174 | 0.060 |
Why?
|
| Random Allocation | 3 | 2017 | 148 | 0.060 |
Why?
|
| Lower Body Negative Pressure | 1 | 2025 | 3 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2009 | 353 | 0.060 |
Why?
|
| Pulse Wave Analysis | 2 | 2015 | 29 | 0.060 |
Why?
|
| Knee | 2 | 2021 | 25 | 0.060 |
Why?
|
| Blood Flow Velocity | 2 | 2017 | 63 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 144 | 0.060 |
Why?
|
| Menstruation Disturbances | 1 | 2004 | 3 | 0.060 |
Why?
|
| Hypertrophy | 2 | 2015 | 44 | 0.060 |
Why?
|
| Ambulatory Care Facilities | 2 | 1994 | 51 | 0.060 |
Why?
|
| Carbohydrate Metabolism | 2 | 1993 | 29 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 1996 | 282 | 0.050 |
Why?
|
| Infant | 2 | 1996 | 964 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 1994 | 2450 | 0.050 |
Why?
|
| Primary Health Care | 2 | 1994 | 151 | 0.050 |
Why?
|
| Lipid Metabolism | 2 | 1993 | 121 | 0.050 |
Why?
|
| Phosphocreatine | 1 | 2001 | 22 | 0.050 |
Why?
|
| Anthropometry | 3 | 2015 | 94 | 0.050 |
Why?
|
| Compliance | 2 | 2011 | 21 | 0.050 |
Why?
|
| Constriction | 2 | 2011 | 14 | 0.050 |
Why?
|
| Calcium, Dietary | 1 | 2000 | 11 | 0.050 |
Why?
|
| Football | 1 | 2001 | 68 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2009 | 2280 | 0.040 |
Why?
|
| Risk Factors | 2 | 2019 | 2030 | 0.040 |
Why?
|
| Refractory Period, Electrophysiological | 2 | 2009 | 21 | 0.040 |
Why?
|
| Periodicity | 2 | 2009 | 17 | 0.040 |
Why?
|
| Diet Records | 1 | 2019 | 10 | 0.040 |
Why?
|
| Picolinic Acids | 1 | 1998 | 2 | 0.040 |
Why?
|
| Wrestling | 1 | 1998 | 7 | 0.040 |
Why?
|
| Athletic Injuries | 1 | 2000 | 116 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2019 | 31 | 0.040 |
Why?
|
| Triglycerides | 1 | 2019 | 120 | 0.040 |
Why?
|
| Recruitment, Neurophysiological | 1 | 2017 | 12 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2019 | 264 | 0.040 |
Why?
|
| Cholesterol | 1 | 2019 | 182 | 0.040 |
Why?
|
| Arterial Pressure | 1 | 2017 | 9 | 0.040 |
Why?
|
| Energy Intake | 1 | 2017 | 69 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2017 | 5 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2000 | 508 | 0.040 |
Why?
|
| Nonlinear Dynamics | 1 | 2017 | 17 | 0.040 |
Why?
|
| Office Visits | 1 | 1996 | 8 | 0.030 |
Why?
|
| Physicians, Family | 1 | 1996 | 13 | 0.030 |
Why?
|
| Capacity Building | 1 | 2016 | 6 | 0.030 |
Why?
|
| Social Perception | 1 | 1996 | 23 | 0.030 |
Why?
|
| Drug Prescriptions | 1 | 1996 | 43 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2015 | 26 | 0.030 |
Why?
|
| Arm | 1 | 2015 | 36 | 0.030 |
Why?
|
| Professional Practice | 1 | 1995 | 8 | 0.030 |
Why?
|
| Thyrotropin | 1 | 1994 | 11 | 0.030 |
Why?
|
| Thyroid Diseases | 1 | 1994 | 8 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 1995 | 94 | 0.030 |
Why?
|
| Volition | 1 | 2014 | 5 | 0.030 |
Why?
|
| Geriatrics | 1 | 1994 | 41 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 1995 | 139 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2014 | 52 | 0.030 |
Why?
|
| Femoral Artery | 1 | 2014 | 58 | 0.030 |
Why?
|
| Creatine Kinase | 1 | 2013 | 13 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Pectoralis Muscles | 1 | 2013 | 13 | 0.030 |
Why?
|
| Pulmonary Ventilation | 1 | 1992 | 10 | 0.030 |
Why?
|
| Extracellular Fluid | 1 | 2012 | 3 | 0.020 |
Why?
|
| Ankle Brachial Index | 1 | 2011 | 34 | 0.020 |
Why?
|
| Pressure | 1 | 2011 | 88 | 0.020 |
Why?
|
| Quality of Life | 1 | 1995 | 465 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2011 | 25 | 0.020 |
Why?
|
| Disabled Persons | 1 | 2011 | 18 | 0.020 |
Why?
|
| Accidental Falls | 1 | 2011 | 31 | 0.020 |
Why?
|
| Liver | 1 | 1993 | 423 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2010 | 44 | 0.020 |
Why?
|
| Vasodilation | 1 | 2011 | 114 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 118 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 404 | 0.020 |
Why?
|
| Heart Rate | 1 | 2011 | 375 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 448 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 408 | 0.020 |
Why?
|
| Rabeprazole | 1 | 2006 | 4 | 0.020 |
Why?
|
| Hydrochloric Acid | 1 | 2006 | 14 | 0.020 |
Why?
|
| Manometry | 1 | 2006 | 36 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2000 | 750 | 0.020 |
Why?
|
| Esophagus | 1 | 2006 | 69 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 2006 | 84 | 0.020 |
Why?
|
| Pliability | 1 | 2005 | 6 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2005 | 30 | 0.020 |
Why?
|
| Isotonic Contraction | 1 | 2005 | 6 | 0.020 |
Why?
|
| Elbow | 1 | 2001 | 15 | 0.010 |
Why?
|
| Body Water | 1 | 2001 | 19 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 2001 | 27 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 116 | 0.010 |
Why?
|
| Animals | 1 | 1993 | 10076 | 0.010 |
Why?
|
| Students | 1 | 2001 | 189 | 0.010 |
Why?
|
| Placebos | 1 | 1998 | 45 | 0.010 |
Why?
|
| Anaerobic Threshold | 1 | 1998 | 19 | 0.010 |
Why?
|
| Densitometry | 1 | 1998 | 9 | 0.010 |
Why?
|
| Insulin | 1 | 1998 | 314 | 0.010 |
Why?
|
| Diet | 1 | 1998 | 225 | 0.010 |
Why?
|
| Thumb | 1 | 1996 | 9 | 0.010 |
Why?
|
| Fingers | 1 | 1996 | 16 | 0.010 |
Why?
|
| Foot | 1 | 1996 | 21 | 0.010 |
Why?
|